Economic evaluation of the use of Innohep® in the treatment of acute pulmonary embolism

Journal of Medical Economics

Volumn 1, Issue 1-4, 1998, Pages 148-162

  Hoffmeyez, U ^a   Lewis, D ^b   Minhas, N ^a   Prabhu, V ^a   Monk, D ^b   Hogan, B ^a  

^a White Plains   (United States)

^b NERA ECONOMIC CONSULTING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; TINZAPARIN;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST CONTROL; DRUG COST; HOSPITAL DISCHARGE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; SIDE EFFECT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031727291     PISSN: 13696998     EISSN: 1941837X     Source Type: Journal    
DOI: 10.3111/199801148162     Document Type: Article

References (9)

1. Barber N and Hoffmeyer U. Comparison of the Cost Effectiveness of Administering Heparin Subcutaneously or Intravenously for the Treatment of Deep Vein Thrombosis. Annals of the Royal College of Surgeons of England, 1993;75:430-433 (Pubitemid 23323452)
2. Barber N and Hoffmeyer U. Heparin Administration Using Prefilled Syringes or Ampoules: A Comparative Cost Effectiveness Study. The International Journal of Pharmacy Practice, 1993; March: 15-17
3. British Medical Journal; Classified Section, inside cover; 1 November 1997
4. British National Formulary Number 34, September 1997, Pharmaceutical Press, Oxon, England
5. Eykyn SJ. Infection and intravenous catheters. Journal of Antimicrobial Chemotherapy, 1984;14:203-208
6. Hirsch J, Hoak, J. Management of Deep Vein Thrombosis and Pulmonary Embolism. Circulation, 1996;93(12):2212-2245
7. Leizorovicz A, Simmoneau G, Decousus H et al. Comparison of efficacy and safety of low-molecular-weight heparins and unfractionated heparin in initial treatment of deep vein thrombosis: a meta-analysis. British Medical Journal, 1994;309:299-304 (Pubitemid 24236428)
8. Simmoneau G, Sors H, Charbonnier B, Page Y, Laaban JP, Azarian R, Laurent M, Hirsch JL, Ferrari E, Bosson JL, Mottier D, Beau BA. Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Acute Pulmonary Embolism. The New England Journal of Medicine, 1997;337(10):663-669 (Pubitemid 27375472)
9. Valette F, Hoffmeyer U, Lloyd A. Economic evaluation of the use of tinzaparin in the treatment of deep vein thrombosis. British Journal of Medical Economics, 1995;8:111-12